We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
45.23%
This Fund
S&P 500
This Quarter
Est. Return
+20.6%
1 Year Est. Return
+45.23%
3 Year Est. Return
+125.62%
5 Year Est. Return
+152.86%
10 Year Est. Return
+730.76%
AUM
$123B
AUM Growth
+$27.7B
(+29%)
Cap. Flow
+$11.7B
Cap. Flow
% of AUM
9.52%
Top 10 Holdings %
Top 10 Hldgs %
25.5%
Holding
2,260
New
268
Increased
1,140
Reduced
651
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.76B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$2.25B |
| 3 |
NVIDIA
NVDA
|
+$1.26B |
| 4 |
Amazon
AMZN
|
+$652M |
| 5 |
Apple
AAPL
|
+$516M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Venture Global Inc
VG
|
+$1B |
| 2 |
Qualcomm
QCOM
|
+$354M |
| 3 |
Johnson & Johnson
JNJ
|
+$192M |
| 4 |
Micron Technology
MU
|
+$166M |
| 5 |
Cboe Global Markets
CBOE
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.01% |
| 2 | Miscellaneous | 20.62% |
| 3 | Healthcare | 8.85% |
| 4 | Financials | 8.52% |
| 5 | Consumer Discretionary | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Alto Neuroscience
ANRO
$1.21B
| $686K | ﹤0.01% |
26,000
-2,500
| -9% | -$57.8K |
|
1952
Telus
TU
$14.1B
| $677K | ﹤0.01% |
63,442
+1,624
| +3% | +$19.8K |
|
1953
Cogent Biosciences
COGT
$5.76B
| $677K | ﹤0.01% |
17,500
-15,100
| -46% | -$528K |
|
1954
Teekay
TK
$1.28B
| $673K | ﹤0.01% |
+67,343
| New | +$843K |
|
1955
GoodRx Holdings
GDRX
$1.17B
| $666K | ﹤0.01% |
231,177
| – | – |
|
1956
Americold
COLD
$4.23B
| $663K | ﹤0.01% |
42,198
-102,904
| -71% | -$1.41M |
|
1957
Repligen
RGEN
$9.85B
| $662K | ﹤0.01% |
4,851
+2,000
| +70% | +$246K |
|
1958
Tradeweb Markets
TW
$21.3B
| $661K | ﹤0.01% |
6,630
+1,404
| +27% | +$152K |
|
1959
Tango Therapeutics
TNGX
$4.04B
| $656K | ﹤0.01% |
+21,000
| New | +$519K |
|
|
DFTX
1960
Definium Therapeutics
DFTX
$5.13B
| $649K | ﹤0.01% |
+13,800
| New | +$341K |
|
1961
Xenon Pharmaceuticals
XENE
$5.55B
| $646K | ﹤0.01% |
10,700
+3,100
| +41% | +$172K |
|
1962
Brookfield Renewable
BEPC
$5.44B
| $643K | ﹤0.01% |
17,303
+495
| +3% | +$19.2K |
|
1963
CALL
D.R. Horton
DHI
$39.7B
| $635K | ﹤0.01% |
3,900
+1,700
| +77% | +$254K |
|
1964
Diamondback Energy
FANG
$53.9B
| $630K | ﹤0.01% |
3,586
-24
| -0.7% | -$4.66K |
|
1965
CALL
Becton Dickinson
BDX
$50.4B
| $620K | ﹤0.01% |
4,100
+1,500
| +58% | +$224K |
|
1966
Dick's Sporting Goods
DKS
$11.1B
| $616K | ﹤0.01% |
2,714
| – | – |
|
1967
Protolabs
PRLB
$1.98B
| $613K | ﹤0.01% |
7,523
-1,592
| -17% | -$112K |
|
1968
Antero Midstream
AM
$10.1B
| $605K | ﹤0.01% |
26,589
+3,784
| +17% | +$82.2K |
|
1969
Thomson Reuters
TRI
$44.3B
| $603K | ﹤0.01% |
7,380
-265,712
| -97% | -$23.2M |
|
1970
Yum China
YUMC
$14.1B
| $601K | ﹤0.01% |
14,699
-685
| -4% | -$31.4K |
|
1971
Dyne Therapeutics
DYN
$3.31B
| $593K | ﹤0.01% |
26,700
+11,700
| +78% | +$218K |
|
1972
Middleby
MIDD
$5.11B
| $578K | ﹤0.01% |
4,161
-1,353
| -25% | -$204K |
|
1973
PUT
Roper Technologies
ROP
$37.6B
| $575K | ﹤0.01% |
1,700
+1,200
| +240% | +$409K |
|
1974
Hackett Group
HCKT
$271M
| $571K | ﹤0.01% |
53,000
-65,800
| -55% | -$769K |
|
1975
Qfin Holdings
QFIN
$984M
| $571K | ﹤0.01% |
36,092
-37,991
| -51% | -$533K |
|
Similar funds
Allianz Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Allianz Asset Management held 2,260 positions worth $123B, up 29% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Allianz Asset Management deployed $11.7B of net new capital in Q2 2026, opening 268 new positions and adding to 1,140 existing holdings. Its largest new stake was Rocket Lab Corp: 2,187,993 shares worth $222M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Venture Global Inc, an estimated $1B trimmed.
- Allianz Asset Management's largest Q2 2026 buy was Rocket Lab Corp: 2,187,993 shares worth $222M.
- Allianz Asset Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $2.76B increase.
- Allianz Asset Management's biggest Q2 2026 reduction was Venture Global Inc, cutting an estimated $1B.
- Allianz Asset Management fully exited CSG Systems International in Q2 2026, selling an estimated $39.2M.
- Allianz Asset Management's ten largest holdings make up 26% of its $123B portfolio in Q2 2026.
- Allianz Asset Management opened 268 new positions and closed 117 in Q2 2026.
- Allianz Asset Management's portfolio value rose 29% quarter-over-quarter to $123B.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.